Table 3.

Top 10 most common treatments during each of the first four lines of therapy in IBM MarketScan® Multi-State Medicaid Database

Treatment line	Therapy/treatment	Patient count	Rank in treatment line	% of patients in treatment line
1 (n = 25,978)	Behavioral and special therapy	17,003	1	65.45
	Centrally acting sympathomimetics	2845	2	10.95
	Imidazoline receptor agonists	2592	3	9.98
	Antipsychotics	2565	4	9.87
	Other (atypical) Antipsychotics	2042	5	7.86
	Selective serotonin reuptake inhibitors	1864	6	7.18
	Anticonvulsant	1711	7	6.59
	Hypnotics and sedatives	1242	8	4.78
	Anxiolytics (excluding BZO)	1043	9	4.01
	Other antidepressants	858	10	3.30
2 (n = 16,853)	Behavioral and special therapy	6935	1	26.70
	Centrally acting sympathomimetics	4380	2	16.86
	Imidazoline receptor agonists	4129	3	15.89
	Antipsychotics	3468	4	13.35
	Other (atypical) Antipsychotics	2725	5	10.49
	Selective serotonin reuptake inhibitors	2706	6	10.42
	Anticonvulsant	2265	7	8.72
	Anxiolytics (excluding BZO)	1436	8	5.53
	Other antidepressants	1261	9	4.85
	Hypnotics and sedatives	1228	10	4.73
3 (n = 13,116)	Behavioral and special therapy	5226	1	20.12
	Centrally acting sympathomimetics	4087	2	15.73
	Imidazoline receptor agonists	3902	3	15.02
	Antipsychotics	3461	4	13.32
	Other (atypical) Antipsychotics	2687	5	10.34
	Selective serotonin reuptake inhibitors	2600	6	10.01
	Anticonvulsant	2258	7	8.69
	Other antidepressants	1360	8	5.24
	Anxiolytics (excluding BZO)	1255	9	4.83
	Hypnotics and sedatives	740	10	2.85
4 (n = 9730)	Behavioral and special therapy	3720	1	14.32
	Imidazoline receptor agonists	3325	2	12.80
	Centrally acting sympathomimetics	3297	3	12.69
	Antipsychotics	3163	4	12.18
	Other (atypical) Antipsychotics	2429	5	9.35
	Selective serotonin reuptake inhibitors	2330	6	8.97
	Anticonvulsant	2037	7	7.84
	Other antidepressants	1350	8	5.20
	Anxiolytics (excluding BZO)	1110	9	4.27
	Hypnotics and sedatives	507	10	1.95